Cite
UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia.
MLA
Weijler, Lisa, et al. “UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia.” Cancers, vol. 14, no. 4, Feb. 2022, p. 898. EBSCOhost, https://doi.org/10.3390/cancers14040898.
APA
Weijler, L., Kowarsch, F., Wödlinger, M., Reiter, M., Maurer-Granofszky, M., Schumich, A., & Dworzak, M. N. (2022). UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia. Cancers, 14(4), 898. https://doi.org/10.3390/cancers14040898
Chicago
Weijler, Lisa, Florian Kowarsch, Matthias Wödlinger, Michael Reiter, Margarita Maurer-Granofszky, Angela Schumich, and Michael N. Dworzak. 2022. “UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia.” Cancers 14 (4): 898. doi:10.3390/cancers14040898.